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Background: The aim of the study was to investigate the prevalence of faecal carriage of extended-spectrum
beta-lactamase (ESBL)-producing Enterobacteriaceae among residents living in nursing homes and to compare
it with a corresponding group of elderly people living in their own homes.
Methods: A total of 160 persons participated in the study between February and April 2014, 91 were residents in
nursing homes (n = 10) and the remaining 69 were elderly living in their own homes. In addition to performing faecal
samples, all participants answered a standardized questionnaire regarding known risk factors for ESBL-carriage.
Results: There was no significant difference between the groups, as 10 of the 91 (11 %) residents from nursing homes
were ESBL-carriers compared with 6 of 69 (8,7 %) elderly living in their own homes. There was no significant difference
between the groups. The total prevalence was 10 %. A univariate analysis revealed that the only studied risk factor
significantly associated with ESBL-carriage was recent foreign travel (p = 0,017). All ESBL-positive isolates were Escherichia
coli and there was a high degree of co-resistance to other antibiotics. All isolates (n = 17) were susceptible to imipenem
and amikacin.
Conclusion: Residents of nursing homes as well as elderly living in their own homes have high rates of faecal carriage
of ESBL-producing bacteria. These findings may affect the choice of empirical antibiotic treatment of severe infections in
older adults.
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The rapid increase of ESBL-producing bacteria is a grow-
ing problem, and has been described as a pandemic [1].
Reported risk factors for carriage and infection include
antibiotic treatment, age ≥ 65 years, recent hospitalisation,
prolonged hospital stay, recent surgery, recurrent UTIs,
travel to foreign countries, severe illness, immobilization
and residence at nursing home [2–8]. However, ESBL-
carriage occurs in patients with no apparent risk factors as
well [2, 9]. Age is a risk factor, but a Swedish study has
shown that the median age among women infected with
ESBL-producing bacteria has decreased from 62 to 52 y in* Correspondence: johan.tham@med.lu.se
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[10]. These risk factors are especially important to con-
sider when treating patients with severe septicemia or sep-
tic shock empirically.
Even though the prevalence of ESBL-producing bac-
teria in Sweden is low in an international perspective,
there has been a dramatic increase in the number of
reported cases since 2007. In 2013 the number of
reported cases were 8132, compared to the 7225
reported cases the previous year [11]. European Centre
for Disease Prevention and Control (ECDC) registers and
presents country prevalence data for resistant bacteria
among invasive isolates, including Escherichia coli with
resistance to third-generation cephalosporins from 30
European countries. The prevalence in Sweden wass distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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with a prevalence as high as 38.1 % [12]. The prevalence of
ESBL-carriage in the general population is not well-known,
however. A Swedish study estimating the prevalence of
ESBL-carriage among patients at Primary Health Care
Units, which may represent a relatively healthy population,
saw a rise from 2.1 to 3 % 2010, compared to various hos-
pital wards where the prevalence increased from 1.8 % in
2008 to 6.8 % in 2010 [13]. Another Swedish study investi-
gated the prevalence of ESBL-carriage among patients
admitted to a surgery ward and found it to be 5 % [14].
Studies of faecal carriage of ESBL-producing Enterobacteri-
aceae in nursing homes in different countries have showed
a wide range of prevalence estimates, ranging from 3 %
(Sweden), 6.2 % (Belgium), and 11.2 % (Germany) to 40.5 %
in Northern Ireland [8, 15–17].
Infections with ESBL-producing Enterobacteriaceae
have dire clinical and economical consequences, including
higher mortality, higher costs and prolonged hospital stays
[18–21]. The major risk associated with colonization is
progress to infection among hospitalized patients [22].
This cohort also serves as a reservoir for ESBL-producing
Enterobacteriaceae [22–24], increasing the risk of spread
to other patients, especially when there is poor adherence
to hygiene routines [22, 23, 25, 26]. A Swedish study ana-
lyzed the ESBL-producing Enterobacteriaceae in a nursing
home setting via pulsed-field gel electrophoresis (PFGE)
and the result indicated a person-to-person transmission
via the staff ’s hands or clothes [15]. A further risk for
patients infected with ESBL-producing Enterobacteriaceae
is receiving inadequate empirical antibiotic treatment [27],
which is the main reason behind the higher mortality in
this group.
Only elderly that are requiring significantly care 24/7
are staying at nursing homes in Sweden since we have a
well-developed tradition to take care of elderly at their
own homes as long as possible. At nursing homes in
Sweden there are usually nurses during daytime and doc-
tors linked to the homes. The aim of this study was to
investigate the prevalence of fecal ESBL-carriage in a nurs-
ing home setting and compare it with a corresponding
population of elderly that still live in their own homes.
Methods
Study design
The study was designed as a cross-sectional comparison
study in February to April 2014 to investigate the preva-
lence of fecal carriage of ESBL-producing Enterobacteri-
aceae in a nursing home setting compared with elderly
living in their own homes. The study was carried out in
the cities of Malmö and Lund in Sweden. In Malmö and
Lund there are 59 and 16 nursing homes, respectively.
Nursing homes that exclusively housed residents with
dementia were excluded. A total of 30 nursing homeswere contacted. In each of these nursing homes, a con-
tact person (usually a nurse) provided a list of potential
participants with the ability to provide informed consent.
Elderly that had stayed at the nursing home of one
month or more were eligible for inclusion. Each resident
had a room of his or her own with separate toilet and
shower.
Elderly with an age > 60 y living in their own homes
were approached on a total of 8 meeting places for eld-
erly. Ethical approval for the study was obtained from
the Research Ethics Committee of the University of
Lund 2013/898.
Data collection
Rectal bacterial samples were acquired using a rectal
swab pin (eSwab, Copan, Brescia, Italy). In the nursing
homes, the samples were collected by a medical student.
In the meeting places for the elderly the participants
were collecting the samples themselves after a standard-
ized instruction. One sample per person was obtained.
Every participant answered a standardized questionnaire
regarding foreign travel, treatment with antibiotics, surgical
procedures or hospital stay the last six months and preva-
lence of chronic heart disease, COPD, other chronic lung
disease, neurological disease and stroke, diabetes mellitus,
autoimmune disease, active cancer, hematological disease,
liver failure, kidney failure, immunosuppressive treatment
corresponding a daily dose of ≥ 5 mg prednisolone and
length of stay at the nursing home. When needed, this in-
formation was obtained from the nurse in charge.
Microbiological methods
All samples were transported in Amies medium (Copan,
Brescia, Italy) to the Laboratory of Microbiology at Malmö
University Hospital within 24 h. The samples were inocu-
lated on agar plates with medium selective for cephalo-
sporin resistance (ChromID ESBL, Bio-Mérieux™). All
isolates obtained from these plates were further examined
for ESBL production through synergy testing on Müller-
Hinton agar plate (Oxoid Thermo Fischer) with discs con-
taining cefpodoxime and ESBL- and AmpC-inhibitor
(AmpC & ESBL Detection Set, Mast Group Ltd, Meyerside,
UK). Antimicrobial susceptibility testing was performed on
the ESBL-positive isolates using the disk diffusion method
according to the Swedish Reference Group of Antibiotics
method [28, 29]. The species determination was performed
using MALDI-TOF. MIC determination was performed
using E-test strips (Biomerieux, Marcy-l'Étoile, France).
Statistics
Statistical analysis was performed using IBM SPSS ver-
sion 22 (IBM Corporation, New York, USA). The ana-
lysis of risk factors was performed using Pearson’s χ2 or
Fischer’s exact test, and 95 % confidence intervals were
Blom et al. BMC Infectious Diseases  (2016) 16:111 Page 3 of 6calculated using the method of Clopper and Pearson. Man-
n—Whitney U test was performed calculating p-values in
age between both groups. An unadjusted p-value < 0.05 was
considered statistically significant.
Results
A total of 30 nursing homes were approached, 18 in
Malmö and 12 in Lund. Of these, ten decided to partici-
pate, seven in Malmö and three in Lund. A total of 91
residents were recruited and subsequently screened. Ten
residents denied participation after the information
about the study was given. In the group of elderly living
at home a total of 69 individuals were screened after
they accepted participation. A total of 160 people were
screened.
Descriptive data
The median age in the nursing home cohort and control
cohort was 89 and 78 years, respectively. The median age
of the two groups together was 85 years. There was a
female dominance in both groups, 69 and 74 % respect-
ively. The descriptive characteristics and the results from
the questionnaire in the two cohorts is shown in Table 1
In the nursing home cohort, the univariate analysis re-
vealed significantly more hospital stays and recent anti-
biotic treatments, as well as higher proportions of chronic
heart disease, COPD and neurological diseases. There was
a difference in age where occupants at nursing homes
were significantly older than study participants living in
their own homes (p < 0.0001). No age differences were
seen between ESBL and non-ESBL carriers for the whole
study population, nor within the nursing-home or the
non-nursing home group. However, international travel
was significantly more frequent among the elderly living
in their own homes (p = <0.001, Table 1).
Prevalence of ESBL-carriage
The total prevalence of faecal carriage of ESBL-producing
Enterobacteriaceae was 10 % (16/160; 95 % CI 5.8–15.7 %).
In the nursing home cohort ten residents were ESBL-
carriers, i.e. 11 % (95 % CI 5.9–19.2 %), and in the control
cohort six individuals tested positive (8.7 % (95 % CI 3.7–
18 The median age for the ESBL-carriers in the respective
cohorts were 90 and 70.5 years. The majority of the carriers
of ESBL-positive bacteria were women, 69 %, which is rep-
resentative for the two groups (Table 2). The difference in
prevalence between the two groups is not statistically sig-
nificant (p = 0.632). In four of the ten nursing homes ESBL-
producing bacteria were not isolated at all.
Information on isolated bacteria
All of the isolates of the ESBL-producing Enterobacteria-
ceae were E. coli. One person was carrying two different
isolates with different resistance pattern. All of the ESBL-producing isolates (n = 17) were susceptible to imipenem
and amikacin. The resistance pattern of the strains is
shown in Table 3. Nine out of the 17 isolates were resist-
ant against ≥ 2 antibiotic classes in addition to betalactam
antibiotics.
Risk factors for carriage of ESBL-producing E. Coli
Six out of 16 ESBL-carriers had travelled abroad in the
past 6 months and five of these individuals were elderly
living in their own homes. International travel was the
only statistically significant association with ESBL-
carriage (p = 0.017). Six persons had received antibiotic
treatment in the past 6 months, all of them residents in
nursing homes. For one of the ESBL-carriers, no appar-
ent risk factor for ESBL-carriage was identified.
Discussion
In this cross-sectional comparison study we found no dif-
ference in the prevalence of ESBL-producing Enterobacte-
riaceae among nursing home residents and the elderly
living in their own homes (11 and 8.7 % respectively). We
found that a total of 10 % were ESBL-carriers among all of
the elderly in the study, which was higher than expected.
Our investigation has limitations. We did not perform
PFGE, rep-PCR or MLST on isolates to examine the possi-
bility of spread of the ESBL-producing Enterobacteriaceae
between the elderly. However, an analysis of the respective
resistance patterns was performed, and it showed wide-
spread resistance to trimethoprim-sulfametoxazole and
ciprofloxacin, two widely used antibiotics against common
infections like UTIs. Another limitation is that only faecal
sample per participant was collected, and an intermittent
secretion of ESBL-producing bacteria could theoretically
have been missed [17]. In total 160 persons were screened,
a higher number would have increased the statistical power
and perhaps the results could have been different. We
don’t think so due to the fact that the healthy elderly is
travelling a lot (in Sweden) and this seems to be of just as
high importance to become rectal carrier of ESBL: s as
staying at a nursing home. However, the risk for a type II
error cannot be fully excluded in this material.
The two major reasons for not participate in the study
was due to shortage of staff and a high ratio of residents
suffering from dementia. The shortage of staff was an ar-
gument from some of the nursing homes that declined
to participate, but we haven’t performed a survey over
the staffing levels in the actual nursing homes. The size
of the nursing home were not an important factor
regarding participation in the study. Rooney et al. have
hypothesized that nursing homes that participate in this
kind of study are the ones that are sufficiently staffed
and therefore are better equipped to observe hygiene
routines [17]. In line with this, Andersson et al. reports
that lack of time is the main reason why infection
Table 1 Demographics and risk factors
Variable Nursing home (n = 91) Living at home (n = 69) P-value
Age (years) 65–102 60–98 –
Age median (years) 89 78 –
Female 63 (69 %) 51 (74 %) –
Male 28 (31 %) 18 (26 %) –
Hospital staya 15 (16.5 %) 3 (4.3 %) 0,016
Surgerya 2 (2.2 %) 2 (2.9 %) 1
Foreign travela 1 (1.1 %) 23 (33.3 %) <0,001
Hospital stay abroada 0 0 –
Chronic heart disease 31 (34.1 %) 11 (15.9 %) 0,01
COPD 10 (11.0 %) 1 (1.4 %) 0,024
Other chronic lung disease 5 (5.5 %) 4 (5.8 %) 1.00
Neurological disease, stroke 23 (25.3 %) 6 (8.7 %) 0.007
Diabetes mellitus 7 (7.7 %) 10 (14.5 %) 0.167
Autoimmune disease 8 (8.8 %) 3 (4.3 %) 0.353
Cancer 10 (11.0 %) 2 (2.9 %) 0.054
Haematological disease 1 (1.1 %) 0 1.00
Liver failure 1 (1.1 %) 0 1.00
Kidney failure 3 (3.3 %) 0 0.26
Immunosuppressive treatmentb 0 0 –
Antibiotic treatmenta 25 (27.5 %) 5 (7.2 %) 0.001
aThe past six months bCorresponding Prednisolon > 5 mg/day
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creases the risk of spreading potential ESBL-producing
bacteria via the staff ’s hands or clothes [9, 15]. Only 91
of 434 residents in the nursing homes were screened.
The main reasons for this loss was dementia diagnosis,
but also severe illness and immobilization of the resi-
dents. Immobility, comorbidity and severe illness are risk
factors for colonization with ESBL-producing Enterobac-
teriaceae, and not being able to include the residents
with these risk factors might affect the result [4, 8]. In
the group of elderly staying at home, when we finally
found them there were only a few who declined partici-
pation so we did not perform any non-response
analyzation.
Many nursing home residents per definition have risk
factors for ESBL colonization and living at a nursing
home is a risk factor per se [2, 4]. In this study, the
ESBL-positive residents at nursing homes had betweenTable 2 Characteristics ESBL-positive (n = 16)
Participants Nursing home Living at home Total
Female n (%) 7 (70) 4 (67) 11 (69)
Male n (%) 3 (30) 2 (33) 5 (31)
Total n (%) 10 (63) 6 (37) 16 (100)
Age (years) 75–97 67–81 67–97
Age (years) median 90 70,5 83,5two and four established risk factors for colonization.
Assessment of risk factors is therefore an important in-
strument to find patients who could be at risk of being
colonized with ESBL-producing Enterobacteriaceae.
Nine of the 17 ESBL-positive isolates were resistant
to ≥ 2 antibiotic classes in addition to betalactam antibi-
otics, which may complicate the treatment of common
infections. The most common findings were resistance
to ciprofloxacin and trimethoprim-sulfametoxazole, both
antibiotics commonly used against UTIs and one has to
consider the choice of antibiotics against this condition
to get full effect and not to drive the resistance.
There was a female dominance in both study popula-
tions, and this corresponds partly with the representa-
tion of gender in Sweden among the elderly: in 2013,
60 % of individuals in the ages between 80 and 89 years
[30] were female. The difference in age between the
ESBL-positive in the two groups were 20 years (median
age 90 and 70.5 years respectively), which in part reflects
the difference in age between the two populations, but it
also suggests the co-existence of different categories of
individuals that become colonized with ESBL-producing
Enterobacteriaceae, with different risk factors. Brolund
et al. has shown that the median age of infected female
patients in Sweden has decreased from 62 to 52 y be-
tween 2007 and 2011, which indicates a higher number
of younger, healthier people being colonized with ESBL-
Table 3 Antibiotic resistance ESBL-producing E. coli-isolates
(n = 17)
Antibiotic Resistance in ESBL-producing
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acquisition, which is a shift from earlier clinical picture
where the nosocomial setting with elderly patients with
comorbidity dominated [10]. Five of the six elderly living
at home that were ESBL-positive had foreign travel as
risk factor, whereof four had travelled outside the Nordic
countries. Foreign travel was the only statistically signifi-
cant connection to ESBL-carriage (p = 0.017), and has in
Sweden been reported to be a major risk factor for ESBL
acquisition, [24].
To our knowledge there is only one earlier study of
the prevalence of faecal carriage of ESBL-producing
Enterobacteriaceae in a nursing home setting in Sweden
2008, and this showed a prevalence of 3 % [15]. Other
European studies have shown prevalence numbers ran-
ging from 6.2 to 40.5 % [8, 17]. These numbers, along
with our result, indicates that nursing homes may act as
a reservoir for ESBL-producing bacteria. These results
should be taken in consideration when treating these
groups of patients if they develop severe sepsis or septic
shock.
Conclusions
The prevalence of ESBL-producing Enterobacteriaceae
in the nursing homes studied has increased, but not
more than among the healthy elderly population in gen-
eral. This depends mainly on the fact that there are dif-
ferent risk factors in these two groups, and foreign
travel—an established risk factor—has become far more
common among healthy elderly people, leading to an in-
creased risk of being colonized with ESBL-producing
Enterobacteriaceae when travelling to countries and
areas where the prevalence is higher. The risk of infec-
tion caused by ESBL-producing Enterobacteriaceae also
increases the risk of getting inadequate initial empirical
antibiotic treatment, which in turn increases the mortal-
ity in severe infections [18, 20, 21]. Our study showed
that 1 of 10 elderly people carry ESBL-producing E. coli,
which questions the current empiric antibiotic treatment
of elderly with certain risk factors [27]. It would be de-
sirable in future studies to include the residents withdementia or immobilization, to have a fuller picture, and
to have a better match between the two groups regard-
ing age and risk factors to be able to help these vulner-
able individuals in the future.
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